Simoctocog alfa Recruiting Phase 2 Trials for Hemophilia A With Inhibitors Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04592692A Pharmacokinetic and Clotting Activity Study of FVIII-PEGLip